Effects of intensive blood-pressure control in type 2 diabetes mellitus

William C. Cushman, Gregory W. Evans, Robert P. Byington, David C. Goff, Richard H. Grimm, Jeffrey A. Cutler, Denise G. Simons-Morton, Jan N. Basile, Marshall A. Corson, Jeffrey L. Probstfield, Lois Katz, Kevin A. Peterson, William T. Friedewald, John B. Buse, J. Thomas Bigger, Hertzel C. Gerstein, Faramarz Ismail-Beigi

Research output: Contribution to journalArticlepeer-review

2456 Scopus citations

Abstract

Background: There is no evidence from randomized trials to support a strategy of lowering systolic blood pressure below 135 to 140 mm Hg in persons with type 2 diabetes mellitus. We investigated whether therapy targeting normal systolic pressure (i.e., <120 mm Hg) reduces major cardiovascular events in participants with type 2 diabetes at high risk for cardiovascular events. Methods: A total of 4733 participants with type 2 diabetes were randomly assigned to intensive therapy, targeting a systolic pressure of less than 120 mm Hg, or standard therapy, targeting a systolic pressure of less than 140 mm Hg. The primary composite outcome was nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes. The mean follow-up was 4.7 years. Results: After 1 year, the mean systolic blood pressure was 119.3 mm Hg in the intensivetherapy group and 133.5 mm Hg in the standard-therapy group. The annual rate of the primary outcome was 1.87% in the intensive-therapy group and 2.09% in the standard-therapy group (hazard ratio with intensive therapy, 0.88; 95% confidence interval [CI], 0.73 to 1.06; P = 0.20). The annual rates of death from any cause were 1.28% and 1.19% in the two groups, respectively (hazard ratio, 1.07; 95% CI, 0.85 to 1.35; P = 0.55). The annual rates of stroke, a prespecified secondary outcome, were 0.32% and 0.53% in the two groups, respectively (hazard ratio, 0.59; 95% CI, 0.39 to 0.89; P = 0.01). Serious adverse events attributed to antihypertensive treatment occurred in 77 of the 2362 participants in the intensive-therapy group (3.3%) and 30 of the 2371 participants in the standard-therapy group (1.3%) (P<0.001). Conclusions: In patients with type 2 diabetes at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, did not reduce the rate of a composite outcome of fatal and nonfatal major cardiovascular events.

Original languageEnglish (US)
Pages (from-to)1575-1585
Number of pages11
JournalNew England Journal of Medicine
Volume362
Issue number17
DOIs
StatePublished - Apr 29 2010

Fingerprint

Dive into the research topics of 'Effects of intensive blood-pressure control in type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this